BC
BSX icon

Barrett & Company’s Boston Scientific BSX Stock Holding History

Barrett & Company’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.64K Hold
42
– – ﹤0.01% 567
2025
Q4 		$4K Sell
42
-3,400
-99% -$333K ﹤0.01% 547
2025
Q3 		$336K Sell
3,442
-800
-19% -$82.8K 0.12% 102
2025
Q2 		$456K Hold
4,242
– – 0.17% 88
2025
Q1 		$428K Hold
4,242
– – 0.18% 87
2024
Q4 		$379K Buy
+4,242
New +$373K 0.16% 90

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barrett & Company's BSX Position: Q1 2026 in Review

Barrett & Company held its Boston Scientific (BSX) position steady in Q1 2026 at 42 shares worth $2.64K. The position accounts for ﹤0.01% of the portfolio, ranked #567.

Barrett & Company first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $456K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Barrett & Company held 42 shares of Boston Scientific worth $2.64K as of Q1 2026.
  • Barrett & Company left its Boston Scientific share count unchanged in Q1 2026.
  • Boston Scientific made up ﹤0.01% of Barrett & Company's portfolio in Q1 2026, its #567 holding.
  • Barrett & Company first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • Barrett & Company's Boston Scientific position peaked at $456K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.